(Q33506208)

27 July 2017

0 references

1 reference

title

Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia (English)

1 reference

27 July 2017

0 references

chronic schizophrenia

1 reference

1 reference

Surendra P Singh

2

0 references

author name string

Vidhi Singh

series ordinal

1

1 reference

PubMed ID

19775502

27 July 2017

Kelvin Chan

series ordinal

3

1 reference

27 July 2017

24 September 2009

1 reference

27 July 2017

15

1 reference

The International Journal of Neuropsychopharmacology

inferred from page(s)

published in

1 reference

27 July 2017

13

1 reference

27 July 2017

2

1 reference

27 July 2017

257-271

1 reference

The immune system and schizophrenia. An integrative view.

27 July 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Prevalence of bipolar II disorder in atypical depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Integrated approaches towards drug development from Ayurveda and other Indian system of medicines

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficulties

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Antioxidant action of Ginkgo biloba extract EGb 761.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Comparison of antioxidant activity in commercial Ginkgo biloba preparations

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

The CNS effects of Ginkgo biloba extracts and ginkgolide B.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Oxidative mechanisms and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Oxygen radicals and neuropsychiatric illness. Some speculations

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Association between priapism and concurrent use of risperidone and Ginkgo biloba

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Effects of over- and under-expression of Cu,Zn-superoxide dismutase on the toxicity of glutamate analogs in transgenic mouse striatum.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Ginkgo biloba extract-induced relaxation of rat aorta is associated with increase in endothelial intracellular calcium level

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 1. Protective effect of Ginkgo biloba extract (EGb 761)

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Extract of Ginkgo biloba added to haloperidol was effective for positive symptoms in refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

The effect of extract of ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Ginkgo biloba for cerebral insufficiency

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Role of free radicals and catalytic metal ions in human disease: an overview

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Relations among clinical scales in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Analysis of terpenelactones in Ginkgo biloba by high performance liquid chromatography and evaporative light scattering detection

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Complementary medicines in psychiatry: review of effectiveness and safety

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Review: adding Chinese herbal medicine to antipsychotics may improve some outcomes in schizophrenia, but more high quality trials are needed

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Protective effects of Ginkgo biloba against rat liver carcinogenesis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Ginkgo biloba extract EGb761 reduces the development of amphetamine-induced behavioral sensitization: effects on hippocampal type II corticosteroid receptors.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Ginkgo biloba extract EGb 761 attenuates hippocampal neuronal loss and cognitive dysfunction resulting from chronic restraint stress in ovariectomized rats.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

A meta-analysis of the efficacy of second-generation antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Effectiveness of vitamin E for treatment of long-term tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Beta2-microglobulin abnormalities in antipsychotic-naïve schizophrenia: evidence for immune pathogenesis.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Chinese medicinal materials and their interface with Western medical concepts

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Interpreting Results and Drawing Conclusions

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Enzymes of the antioxidant defense system in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

The negative symptoms of schizophrenia: a cognitive perspective

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Chinese herbal medicine for schizophrenia: cochrane systematic review of randomised trials.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

The Ginkgo biloba extract, EGb761, increases synaptosomal uptake of 5-hydroxytryptamine: in-vitro and ex-vivo studies.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Best practices: An initiative to curtail the use of antipsychotic polypharmacy in a state psychiatric hospital

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Polypharmacy with second-generation antipsychotics: a review of evidence

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

A review of 12 commonly used medicinal herbs

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990654

7 January 2021

10.1017/S1461145709990654

Identifiers

DOI

1 reference

27 July 2017

1 reference

PubMed ID

19775502